IL22 and cancer: In GBM, the proinflammatory cytokines IL-17 and IL-22 have been identified as cancer-promoting molecules activating oncogenic STAT3 signaling, thereby protecting GBM cells from apoptosis, promoting GBM proliferation and enhancing invasion [26,27,44].